However, a recent detailed analysis of patient-derived prostate cancer organoids reported that PTEN loss did not cause selective sensitivity to PI3K isoform inhibitors and that changes in isoform dependency might take place [88]. The gene discussed is PIK3CD; the disease is prostate cancer.